Search results for: hospital

Careful Management Improves Safety of Stem Cell Transplantation in Crohn’s

Will Boggs, MD | December 13, 2015

NEW YORK (Reuters Health)—Careful use of antibiotics and corticosteroids can substantially improve the safety of autologous hematopoietic stem transplantation (HSCT) in patients with refractory Crohn’s disease (CD), researchers from Spain report. “Autologous HSCT is feasible but it is associated with severe adverse events and even mortality,” Dr. Elena Ricart from Hospital Clinic de Barcelona tells…

Dr. Michael Weinblatt Discusses Current & Future RA Therapies

Richard Quinn | December 11, 2015

According to former ACR President Michael Weinblatt, MD, the future of drug therapies for patients with RA rests in the careful and intelligent prescription of current medications and treatment combinations, as well as better patient access through lower costs…

FDA Approves Drug to Counter Opioid ODs

Michele B. Kaufman, PharmD, BCGP | December 9, 2015

The FDA recently approved a form of naloxone hydrochloride in a nasal spray that will help counter opioid overdoses. The FDA also approved an ibuprofen injection as an adjunct to opioids for use in children 6 months and older…

NPs & PAs May Improve Care in Rheumatology Practices

Arthritis Care & Research | December 2, 2015

A recent study examined the outcomes of care for RA patients provided by nurse practitioners or physician assistants working in tandem with rheumatologists, compared with that provided exclusively by rheumatologists. Over the two-year course of the study, results indicated that not only was care not compromised, but RA disease activity control may actually have been slightly better in these practices…

Etanercept Biosimilars Promising in Clinical Studies

Michele B. Kaufman, PharmD, BCGP | December 2, 2015

In multiple clinical studies, investigational biosimilars for etanercept were shown to be safe and effective for treating rheumatoid arthritis and moderate to severe plaque psoriasis…

Idiopathic Lung Fibrosis—Check for ANCA

Lara C. Pullen, PhD | November 30, 2015

New research recommends that doctors test the sera of patients with idiopathic pulmonary fibrosis for anti-neutrophil cytoplasmic antibodies (ANCA), as well as closely monitor this population for signs of lung vasculitis…

Five Charged in $600 million California Healthcare Fraud Scheme

Dan Whitcomb | November 29, 2015

LOS ANGELES (Reuters)—The former chief financial officer of a California hospital and four other people have been charged in a series of health care kickback schemes that generated nearly $600 million in fraudulent billings for spinal surgeries, prosecutors said on Tuesday. All five defendants have agreed to cooperate in a wide-ranging federal investigation into the…

Oxycodone Capsules Put on Hold; Clinical Trials for Lupus Nephritis & SLE Therapies

Michele B. Kaufman, PharmD, BCGP | November 25, 2015

Due to a lawsuit, the FDA has issued only tentative approval for an extended-release oxycodone capsule. Obinutuzumab is in clinical trials for lupus nephritis, and subcutaneous belimumab is being tested for SLE…

How to Stay on Top of the Science

Richard Quinn | November 20, 2015

For rheumatologists with busy schedules, staying up to date on the latest research can be difficult. Here are a few tips to help you review and prioritize the literature that could affect your practice…

Autoimmune Diseases Common in Patients with Vitiligo

Will Boggs, MD | November 19, 2015

NEW YORK (Reuters Health)—Patients with vitiligo commonly have other autoimmune diseases, according to a cross-sectional study. “Vitiligo is a systemic disease with multiple comorbidities,” Dr. Iltefat Hamzavi from Henry Ford Hospital in Detroit, Mich., told Reuters Health by email. “The number of patients with neurologic diseases and inflammatory disease was much higher than we anticipated.”…